ArticleFrontiers in immunology2025

Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer.

Daun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.